Northland Securities Reaffirms Their Buy Rating on Spectral AI (MDAI)
H.C. Wainwright Maintains Spectral AI(MDAI.US) With Buy Rating, Maintains Target Price $3.5
Northland Securities Initiates Spectral AI(MDAI.US) With Buy Rating, Announces Target Price $6
Northland Securities Remains a Buy on Spectral AI (MDAI)
Spectral AI Analyst Ratings
H.C. Wainwright Maintains Spectral AI(MDAI.US) With Buy Rating, Maintains Target Price $3.5
Spectral AI Analyst Ratings
Spectral AI Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Spectral AI (MDAI) and Pyxis Oncology (PYXS)
Spectral AI Poised for Growth: A Buy Rating From Ryan Zimmerman
Spectral AI Analyst Ratings